Affordable Access

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).

Authors
Type
Published Article
Journal
Journal of glaucoma
Publication Date
Volume
2 Suppl A
Pages
1–2
Identifiers
PMID: 19920456
Source
Medline

Abstract

Statistics

Seen <100 times